Status:
UNKNOWN
Anemia and Red Blood Cells Transfusion in Oncological Surgery
Lead Sponsor:
University Hospital, Brest
Conditions:
Anemia
Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Oncologic patients experience anemia and anemia is associated with poor prognosis. Transfusion is associated with adverse events, and equipoise remains on the optimal transfusion strategy in oncologic...
Detailed Description
Between 36 and 75% of oncologic patients experience anemia and anemia is associated with poor prognosis. Up to 40% of surgical oncologic patients receive red blood cells (RBC). However, transfusion is...
Eligibility Criteria
Inclusion
- Surgery for cancer
- Admission to intensive care
Exclusion
- no consent
Key Trial Info
Start Date :
February 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2019
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04101240
Start Date
February 7 2019
End Date
November 30 2019
Last Update
September 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Brest, hôpital de la Cavale Blanche
Brest, France, 29200